PTC Therapeutics
PTCT
#2634
Rank
C$9.57 B
Marketcap
C$115.45
Share price
-3.71%
Change (1 day)
72.78%
Change (1 year)

PTC Therapeutics (PTCT) - Total debt

Total debt on the balance sheet as of March 2026 : C$0.56 Billion

According to PTC Therapeutics 's latest financial reports the company's total debt is C$0.56 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

PTC Therapeutics - Total debt on balance sheet (from 2012 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$3.70 B4.55%
2024-12-31C$3.54 B19.93%
2023-12-31C$2.95 B49.08%
2022-12-31C$1.98 B22.59%
2021-12-31C$1.61 B201.77%
2020-12-31C$0.53 B25.13%
2019-12-31C$0.42 B105.54%
2018-12-31C$0.20 B14.36%
2017-12-31C$0.18 B38.09%
2016-12-31C$0.13 B3.59%
2015-12-31C$0.12 B
2014-12-31N/A-100%
2013-12-31C$0.05 M-98.93%
2012-12-31C$4.85 M-59.16%
2011-12-31C$11.89 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
C$66.74 B 11,795.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
C$2.82 B 402.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$0.26 B-52.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$1.47 B 162.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.11 B-79.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
C$69.93 M-87.53%๐Ÿ‡บ๐Ÿ‡ธ USA